Literature DB >> 12904417

Molecular epidemiology of Haemophilus influenzae type b isolated from children with clinical cases of conjugate vaccine failures.

José Campos1, Belén Aracil, Federico Román, María Pérez-Vázquez.   

Abstract

We analyzed eight invasive Haemophilus influenzae strains isolated from individual children vaccinated appropriately for their ages. Five of the strains were type b and three were nontypeable strains. Children infected with nontypeable strains had a protective level of anti-H. influenzae type b antibodies, while only one of the children whose cases represented true vaccine failure did.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12904417      PMCID: PMC179828          DOI: 10.1128/JCM.41.8.3915-3918.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Effectiveness of vaccination for Haemophilus influenzae type b.

Authors:  David Garner; Vivienne Weston
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

2.  Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska.

Authors:  K Galil; R Singleton; O S Levine; M A Fitzgerald; L Bulkow; M Getty; B A Perkins; A Parkinson
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

3.  Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed.

Authors:  Mijke A Breukels; Els Jol-van der Zijde; Maarten J D van Tol; Ger T Rijkers
Journal:  Clin Infect Dis       Date:  2001-12-07       Impact factor: 9.079

4.  Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants.

Authors:  M A Breukels; L Spanjaard; L A Sanders; G T Rijkers
Journal:  Clin Infect Dis       Date:  2001-05-16       Impact factor: 9.079

Review 5.  Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates.

Authors:  H Peltola
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

Review 6.  The UK Hib vaccine experience.

Authors:  P T Heath; J McVernon
Journal:  Arch Dis Child       Date:  2002-06       Impact factor: 3.791

7.  Serotyping discrepancies in Haemophilus influenzae type b disease--United States, 1998-1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-08-16       Impact factor: 17.586

8.  Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection.

Authors:  Shabir A Madhi; Karen Petersen; Manikant Khoosal; Robin E Huebner; Nontombi Mbelle; Rosalia Mothupi; Haroon Saloojee; Heather Crewe-Brown; Keith P Klugman
Journal:  Pediatr Infect Dis J       Date:  2002-04       Impact factor: 2.129

9.  Identification of Haemophilus influenzae serotypes by standard slide agglutination serotyping and PCR-based capsule typing.

Authors:  Leslye L LaClaire; Maria Lucia C Tondella; David S Beall; Corie A Noble; Pratima L Raghunathan; Nancy E Rosenstein; Tanja Popovic
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

10.  Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?

Authors:  F R Mooi; I H van Loo; A J King
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

View more
  2 in total

1.  Molecular epidemiology of Haemophilus influenzae type b causing vaccine failures in the United Kingdom.

Authors:  Belén Aracil; Mary Slack; María Pérez-Vázquez; Federico Román; Mary Ramsay; José Campos
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

2.  Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b.

Authors:  José Campos; Margarita Hernando; Federico Román; María Pérez-Vázquez; Belén Aracil; Jesús Oteo; Edurne Lázaro; Francisco de Abajo
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.